ALT

NASDAQStock

Altimmune, Inc.

$3.52-0.08 (-2.34%)

52-Week Range

$3.38
$7.71

Key Stats

Market Cap

310.3M

P/E Ratio

Dividend Yield

Beta

0.17

Volume

2.1M

Avg Volume

3.5M

Performance

1M

-21.23%

3M

-31.82%

6M

+0.28%

YTD

+2.56%

1Y

-39.19%

3Y

-67.06%

5Y

-79.70%

Price Chart

ETF Exposure

ALT is held by 66 ETFs

ETFFund NameWeight
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
IWViShares Russell 3000 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
PreviousPage 2 of 2

About ALT ETF Exposure

Altimmune, Inc. (ALT) is held by 66 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 310.3M, ALT is a widely held institutional stock. The stock currently trades at $3.52. Investors can gain exposure to ALT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALT, sorted by portfolio weight.